« Back
High-throughput Carbonic Anhydrase Activity and Inhibitor Screening Assays
Poster Title: High-throughput Carbonic Anhydrase Activity and Inhibitor Screening Assays
Submitted on 25 Apr 2018
Author(s): Suratna Hazra, Ph.D., Grigoriy Tchaga, Ph.D., and Gordon Yan, Ph.D.
Affiliations: BioVision Inc
This poster was presented at Experimental Biology 2018
Poster Views: 2,234
View poster »

Poster Information
Abstract: Carbonic Anhydrase (CA) is a zinc based metalloprotease present in at least 14 different isoforms in mammals. It catalyzes the reversible hydration of carbon dioxide to form bicarbonate and proton, thus playing an important role in pH and CO2 homeostasis. Changes in CA activity are associated with various diseases such as - glaucoma, type II diabetes mellitus, lung, liver diseases etc. As CA is also an important target for cancer therapy, a robust and sensitive high-throughput carbonic anhydrase activity and inhibitor screening assays are very important tools.
Carbonic anhydrase activity or carbon dioxide hydration rate is widely measured by using potentiometer or a stopped-flow instrument as reflected by the change in pH over time. However, this method is not suitable for high-throughput assay. Consequently, in BioVision Inc. we have launched the first high throughput Carbonic Anhydrase Activity Assay Kit, detecting the esterase activity of this enzyme. This kit utilizes the zinc-hydroxide mechanism for carbon dioxide hydration and hydrolysis of an ester substrate resulting in the release of a chromophore signal that is proportional to the enzyme activity
Summary: BioVision’s Carbonic Anhydrase Activity and Inhibitor Screening Assays provide valuable tools for drug discovery and identifying potential modulators of CA Activity in a high-throughput format. The assay kits are commercially available at Cat # K472-100 and K473-100.Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

ExpiSf™ Expression system: A Chemically Defined Baculovirus-Based System for Enhanced Protein and Virus Production in Sf9 Cells
Kenneth Thompson, Maya Yovcheva, Sara Barnes, Melissa Cross, Katy Irvin, Natasha Lucki, Henry Chiou, and Jonathan Zmuda

Availability and quality of the antimicrobials in the street markets in Port-au- Prince: a pilot study
Théodule Jean-Baptiste, John Carpenter, Kevin Dahl, Wellington Derameau, Rosemela Veillard, John Redford Jacquet, Ludens Osselyn, Albert Figueras

Tres métodos moleculares para la genotipificación del virus de la Hepatitis C (VHC): una estrategia en pos de la seguridad del paciente
Andy Caballero, Sonali Marrero y Karla Montero

Comparación de tres pruebas moleculares para el diagnóstico y la evaluación de la resistencia a claritromicina de H. pylori en heces
Andy Caballero, Nelson Piñero

Dissecting the genomic profile of persistently infecting oncolytic Newcastle disease virus (NDVpi) from cancer RNA-Seq data
Ahmad U1, Chan SC2, Chau DM1, Chia SL5, Abdullah S1,3, Yusoff K5 & Veerakumarasivam A1,4*